Boehringer Ingelheim’s former Head of Medicine for the Diabetes and CardioMetabolism business, Jyothis George (pictured below; view LinkedIn profile), has recently joined Novo Nordisk as the VP of Clinical, Medical, and Regulatory for Northwest Europe. Below, FENIX provides thoughts on George’s move, including insight into why it seems to make sense given Novo’s expanding focus beyond diabetes.